“Patients who received an experimental drug developed at Northwestern University alongside standard chemotherapy were twice as likely to be alive after one year of treatment, compared to those receiving chemotherapy alone. The post New Drug Doubles One-Year Survival in Pancreatic Cancer Trial appeared first on News Center .
Original story
Continue reading at Northwestern Feinberg News
news.feinberg.northwestern.edu
Summary generated from the RSS feed of Northwestern Feinberg News. All article rights belong to the original publisher. Click through to read the full piece on news.feinberg.northwestern.edu.
